Semaglutide for blood sugar control in type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a new medication called semaglutide (similar to Ozempic) in people with type 2 diabetes who are already taking metformin. It aims to see if this medication improves blood sugar control and may also help with weight loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Aged between 18 and 75.
- You have type 2 diabetes.
- Your blood sugar (HbA1c) is between 7.5% and 10.5%.
- You take metformin at a stable dose of at least 1000mg per day for 8 weeks or more.
- Your body mass index (BMI) is between 18.5 and 35.
- You have not had serious diabetes complications or heart events recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational drug, BGM0504, for people recently diagnosed with type 2 diabetes who also have obesity. It aims to see if the drug can help control blood sugar and support weight loss.
This study compares a weekly injection called semaglutide with a calorie-restricted diet to see which helps control blood sugar better. If you have just been diagnosed with type 2 diabetes and have overweight, this trial might help you choose a treatment path.
This study tests whether semaglutide, a medicine that helps control blood sugar and reduce weight, can benefit adults with type 1 diabetes who are overweight. If you qualify, you may receive the drug or a placebo, and the study team will monitor your health closely.
This study tests a new medication called Bofanglutide (an injectable drug, similar to others in its class) to see if it can help control blood sugar in adults with type 2 diabetes. It may also help with weight management. Participants will continue taking their current diabetes medication (metformin).
This study tests a new medicine, NNC0662-0419, in people with type 2 diabetes. You must be willing to lose a lot of weight (more than a quarter of your current weight) as part of the study to see if the medicine helps lower blood sugar.
This study tests if starting two newer diabetes drugs (empagliflozin and semaglutide) soon after diagnosis, along with metformin, helps control blood sugar better than metformin alone. It's for people diagnosed with type 2 diabetes in the last two years who are already taking a high dose of metformin.
Hear when a new Type 2 Diabetes (T2DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.